Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First in Human Study to Assess the Safety and Efficacy of an Implantable Nitinol Device in the Treatment of Stage 3 and 4 Keratoconus

NCT06451718 is registered in ClinicalTrials.gov with Recornea Srl as lead sponsor.

NCT NCT06451718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06451718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First in Human Study to Assess the Safety and Efficacy of an Implantable Nitinol Device in the Treatment of Stage 3 and 4 Keratoconus
Lead sponsor
Recornea Srl
Phase
Not applicable
Overall status
Recruiting
Start date
September 3, 2024
Completion date
February 28, 2027
Enrollment
12 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

keratoconus